Site Search

IMI has a strong diabetes project portfolio, with several projects addressing different aspects of the disease. Some are studying the underlying causes of the disease and the internal processes that lead to the destruction of the cells in the pancreas that produce insulin. Others ...

IMI has had ‘big data’ projects since its creation. Projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease, haematological malignancies (blood cancers), Alzheimer’s disease, and prostate cancer. IMI also boasts a ...

IMI has over 20 projects in this area accounting for around 10 % of IMI’s budget. Most focus on Alzheimer’s disease and other forms of dementia, but we also have projects on Parkinson’s disease, pain, and multiple sclerosis, for example. The projects cover the whole spectrum of ...

EUROPAIN showed that cautious description of expected drug efficacy and side effects may reduce the placebo analgesic response

EMIF’s datasets helped researchers identify plasma proteins that changed in the presence of traditional Alzheimer’s markers, opening new avenues of research

The project is calling on people in the Netherlands to join its study on the ability of digital devices to detect signs of COVID-19 before the user even starts to feel ill.